Jinhai Medical Technology (HKSE:02225) Moat Score: 0/10 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02225 Jinhai Medical Technology Ltd HKSE:02225
61 GF Score
Price HK$6.05
GF Value HK$1.41
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Jinhai Medical Technology Moat Score?

Jinhai Medical Technology has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Jinhai Medical Technology has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Jinhai Medical Technology might have No Moat - No discernible moat.

Jinhai Medical Technology  (HKSE:02225) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Jinhai Medical Technology Moat Score Related Terms

HKSE:02225
61GF Score
Jinhai Medical Technology Ltd HKSE:02225
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jinhai Medical Technology (HKSE:02225) Overvalued in 2026?

Based on GuruFocus' analysis, Jinhai Medical Technology stock appears to be overvalued. The current stock price of HK$6.05 is trading 328.7% above its estimated GF Value™ of HK$1.41. GuruFocus considers Jinhai Medical Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02225:

  • Moat Score: 0
  • GF Value™: HK$1.41 vs. price of HK$6.05 (328.7% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the HKSE:02225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinhai Medical Technology Business Description

Address 1275 Meichuan Road, 3rd Floor, Block East, Putuo District, Shanghai, CHN
Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.
61GF Score

Get the complete analysis for HKSE:02225

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.05
Price
HK$1.41
GF Value